ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)
CAPS Rating:
The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.
RSS Headlines
Fool UK
Recs
Low market cap related to potential for drug candidates. Requires patience - buy on dips